Test Code INRXS International Normalized Ratio (INR), Point of Care, Blood
Useful For
Routine warfarin monitoring
As results may be affected, this test should not be used for patients being treated with direct oral anticoagulants including, but not limited to, rivaroxaban, apixaban, edoxaban, and dabigatran.
This test should not be used for patients being treated with a direct thrombin inhibitor including, but not limited to, hirudin, lepirudin, bivalirudin, or argatroban.
Method Name
Capillary International Normalized Ratio (INR)
Reporting Name
INR, POCT, BReference Values
Standard-intensity warfarin therapeutic range: 2.0-3.0
High-intensity warfarin therapeutic range: 2.5-3.5
Performing Laboratory
MCHS- MankatoTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
85610
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
INRXS | INR, POCT, B | 34714-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
INRXS | INR, POCT, B | 34714-6 |
Day(s) Performed
Monday through Friday